Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4858431
Max Phase: Preclinical
Molecular Formula: C45H45ClF3N5O7
Molecular Weight: 860.33
Molecule Type: Unknown
Associated Items:
ID: ALA4858431
Max Phase: Preclinical
Molecular Formula: C45H45ClF3N5O7
Molecular Weight: 860.33
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCOC(=O)c1[nH]c2cc(Cl)ccc2c1C(C(=O)NC(C)(C)C)N(Cc1cc(F)c(F)c(F)c1)C(=O)CCCCCC#Cc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O
Standard InChI: InChI=1S/C45H45ClF3N5O7/c1-5-61-44(60)39-37(29-17-16-27(46)22-33(29)50-39)40(42(58)52-45(2,3)4)54(23-25-20-31(47)38(49)32(48)21-25)36(56)15-10-8-6-7-9-12-26-13-11-14-28-30(26)24-53(43(28)59)34-18-19-35(55)51-41(34)57/h11,13-14,16-17,20-22,34,40,50H,5-8,10,15,18-19,23-24H2,1-4H3,(H,52,58)(H,51,55,57)
Standard InChI Key: PWKVSHYUQVVESP-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 860.33 | Molecular Weight (Monoisotopic): 859.2960 | AlogP: 7.16 | #Rotatable Bonds: 13 |
Polar Surface Area: 157.98 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 3 |
#RO5 Violations: 2 | HBA (Lipinski): 12 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 10.31 | CX Basic pKa: | CX LogP: 6.67 | CX LogD: 6.67 |
Aromatic Rings: 4 | Heavy Atoms: 61 | QED Weighted: 0.04 | Np Likeness Score: -0.81 |
1. Wang B, Liu J, Tandon I, Wu S, Teng P, Liao J, Tang W.. (2021) Development of MDM2 degraders based on ligands derived from Ugi reactions: Lessons and discoveries., 219 [PMID:33862513] [10.1016/j.ejmech.2021.113425] |
Source(1):